Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The goal of epilepsy therapy: no seizures, no side effects, as soon as possible.

Literature DB >> 14999165

The goal of epilepsy therapy: no seizures, no side effects, as soon as possible.

Jerome Engel¹.

Abstract

Entities: Disease

Mesh：

Substances：
Anticonvulsants

Year: 2004 PMID： 14999165 DOI： 10.1017/s1092852900008452

Source DB: PubMed Journal: CNS Spectr ISSN： 1092-8529 Impact factor: 3.790

Keyword Cloud
Cited

× No keyword cloud information.

8 in total

1. Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial.

Authors: Jerome Engel; Michael P McDermott; Samuel Wiebe; John T Langfitt; John M Stern; Sandra Dewar; Michael R Sperling; Irenita Gardiner; Giuseppe Erba; Itzhak Fried; Margaret Jacobs; Harry V Vinters; Scott Mintzer; Karl Kieburtz
Journal: JAMA Date: 2012-03-07 Impact factor: 56.272

2. Epilepsy surgery in tuberous sclerosis complex (TSC): emerging techniques and redefinition of treatment goals.

Authors: Jeffrey M Treiber; Daniel J Curry; Howard L Weiner; Jonathan Roth
Journal: Childs Nerv Syst Date: 2020-06-13 Impact factor: 1.475

3. Referral pattern for epilepsy surgery after evidence-based recommendations: a retrospective study.

Authors: Zulfi Haneef; John Stern; Sandra Dewar; Jerome Engel
Journal: Neurology Date: 2010-08-24 Impact factor: 9.910

4. Design considerations for a multicenter randomized controlled trial of early surgery for mesial temporal lobe epilepsy.

Authors: Jerome Engel; Michael P McDermott; Samuel Wiebe; John T Langfitt; Giuseppe Erba; Irenita Gardiner; John Stern; Sandra Dewar; Michael R Sperling; Margaret Jacobs; Karl Kieburtz
Journal: Epilepsia Date: 2010-10 Impact factor: 5.864

5. Comparison of brand versus generic antiepileptic drug adverse event reporting rates in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS).

Authors: Md Motiur Rahman; Yasser Alatawi; Ning Cheng; Jingjing Qian; Annya V Plotkina; Peggy L Peissig; Richard L Berg; David Page; Richard A Hansen
Journal: Epilepsy Res Date: 2017-06-13 Impact factor: 3.045

The goal of epilepsy therapy: no seizures, no side effects, as soon as possible.

1. Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial.

2. Epilepsy surgery in tuberous sclerosis complex (TSC): emerging techniques and redefinition of treatment goals.

3. Referral pattern for epilepsy surgery after evidence-based recommendations: a retrospective study.

4. Design considerations for a multicenter randomized controlled trial of early surgery for mesial temporal lobe epilepsy.

5. Comparison of brand versus generic antiepileptic drug adverse event reporting rates in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS).

6. Remission of epilepsy after two drug failures in children: a prospective study.

7. Childhood Epilepsy; Prognostic Factors in Predicting the Treatment Failure.

8. Seizure burden in severe early-life epilepsy: Perspectives from parents.